Jefferies Financial Group Inc. Makes New Investment in Omada Health, Inc. $OMDA

Jefferies Financial Group Inc. acquired a new position in Omada Health, Inc. (NASDAQ:OMDA) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 1,073,991 shares of the company’s stock, valued at approximately $16,948,000.

Several other institutional investors and hedge funds have also bought and sold shares of OMDA. Perceptive Advisors LLC purchased a new stake in Omada Health in the second quarter worth about $44,402,000. Divisadero Street Capital Management LP purchased a new stake in Omada Health in the third quarter worth about $30,510,000. BIT Capital GmbH purchased a new stake in Omada Health in the third quarter worth about $13,639,000. Vanguard Group Inc. lifted its holdings in Omada Health by 642.8% in the third quarter. Vanguard Group Inc. now owns 482,790 shares of the company’s stock worth $10,674,000 after buying an additional 417,790 shares during the period. Finally, Schroder Investment Management Group purchased a new stake in Omada Health in the third quarter worth about $4,440,000.

Insider Buying and Selling

In related news, CEO Sean P. Duffy sold 4,063 shares of the business’s stock in a transaction that occurred on Monday, March 9th. The shares were sold at an average price of $14.34, for a total value of $58,263.42. Following the completion of the transaction, the chief executive officer directly owned 117,598 shares in the company, valued at $1,686,355.32. The trade was a 3.34% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Steven L. Cook sold 1,884 shares of the business’s stock in a transaction that occurred on Friday, March 13th. The stock was sold at an average price of $13.94, for a total transaction of $26,262.96. Following the completion of the transaction, the chief financial officer owned 200,512 shares of the company’s stock, valued at approximately $2,795,137.28. The trade was a 0.93% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 8,776 shares of company stock worth $120,483 in the last three months. Insiders own 6.38% of the company’s stock.

Wall Street Analysts Forecast Growth

OMDA has been the subject of several recent research reports. JPMorgan Chase & Co. lowered their target price on shares of Omada Health from $32.00 to $26.00 and set an “overweight” rating for the company in a report on Thursday, March 12th. Needham & Company LLC reiterated a “buy” rating and set a $28.00 target price on shares of Omada Health in a report on Friday, May 8th. Evercore reiterated an “outperform” rating and set a $20.00 target price on shares of Omada Health in a report on Friday, May 8th. Wells Fargo & Company lifted their target price on shares of Omada Health from $17.00 to $18.00 and gave the company an “equal weight” rating in a report on Friday, May 8th. Finally, Barclays lifted their target price on shares of Omada Health from $18.00 to $20.00 and gave the company an “overweight” rating in a report on Friday, May 8th. Ten analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Omada Health has an average rating of “Moderate Buy” and a consensus price target of $22.91.

Omada Health Price Performance

Shares of NASDAQ OMDA opened at $16.51 on Monday. Omada Health, Inc. has a twelve month low of $10.28 and a twelve month high of $28.40. The firm has a market cap of $981.52 million and a P/E ratio of -61.15. The company has a 50 day moving average of $14.14 and a 200 day moving average of $15.12.

Omada Health (NASDAQ:OMDA) last announced its quarterly earnings data on Thursday, May 7th. The company reported ($0.05) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.03. Omada Health had a negative net margin of 2.22% and a negative return on equity of 1.82%. The company had revenue of $78.05 million during the quarter. As a group, equities analysts expect that Omada Health, Inc. will post -0.04 earnings per share for the current fiscal year.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.